Latest Bone morphogenetic protein Stories
DUBLIN, May 19, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/hdsx2f/bone)
NEW YORK and BOSTON, March 12, 2015 /PRNewswire/ -- Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related
Investors allege that Medtronic misled them about Infuse’s safety profile and potential commercial possibilities. Port Washington, New York (PRWEB) October
NEW YORK, Oct.
NEW YORK, Sept.
Transparency Market Research published a new report “Global Orthobiologics Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019” to its report store.
NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc.
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Another Medtronic Infuse Lawsuit Accuses The Manufacturer of the Infuse Bone Graft For Promoting Use In Non-FDA -Approved Surgical Procedures, Coaching Doctors and Misrepresentation.
UT Arlington and Texas Health Arlington Memorial Hospital are investigating whether bone grown from the body’s own stem cells can replace traditional types of bone grafting.
- The parings of haberdine; also, any kind of fragments.